# Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study]

> **NCT03980236** · NA · TERMINATED · sponsor: **Livongo Health** · enrollment: 21 (actual)

## Conditions studied

- Type 2 Diabetes Treated With Insulin

## Interventions

- **DEVICE:** Livongo-Insulia Study App

## Key facts

- **NCT ID:** NCT03980236
- **Lead sponsor:** Livongo Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-06
- **Primary completion:** 2020-02-27
- **Final completion:** 2020-05-31
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Did not achieve enrollment goal
- **Last updated:** 2021-02-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03980236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03980236, "Feasibility of Using the Livongo-Insulia Study App for Patients With Type 2 Diabetes [Pilot Study]". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03980236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*